Home » Newsletters » BioWorld

BioWorld

June 15, 1993

View Archived Issues

RAC APPROVALS REFLECT GROWTH IN GENE THERAPY

VIRAGEN GETS $1M FROM INVESTMENT COMPANY

BECTON INVESTS $5M IN NEXAGEN

ANTISENSE STRATEGY TO PREVENT HAIR LOSS

IMMULOGIC, MERCK TO CONCLUDE PACT

IVAX TO ACQUIRE JOHNSON PRODUCTS

DIABETIC DOGS THRIVE WITH ISLET TRANSPLANTS

LEAD CANCER TARGET OCCURS OFTEN

ALLERGY ANSWERS DIFFICULT TO COME BY

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...